Givinostat Phase 3 Trial Recruiting Duchenne Patients in North America, Europe
News
A global Phase 3 trial of givinostat — an investigational treatment aiming to boost the muscle regeneration capacity in Duchenne muscular dystrophy patients — is recruiting participants across North America ... Read more